Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-29 Purchase |
2022-08-02 5:02 pm |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
39,382 | $4.25 | $167,374 | 958,446 (Indirect Direct) |
View |
| 2022-07-26 Purchase |
2022-07-28 7:52 pm |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
8,618 | $4.2436 | $36,571 | 919,064 (Indirect Direct) |
View |
| 2022-07-22 Purchase |
2022-07-26 7:38 pm |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
9,444 | $3.7497 | $35,412 | 910,446 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-25 Option Award |
2024-03-28 12:38 pm |
2025-03-25 2034-03-25 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-10-30 Other |
2024-01-16 1:41 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
30,002 | $0 | 60,004 (Direct) |
View |
| 2023-07-03 Tax Withholding |
2023-07-06 5:19 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Former Chief Executive Officer |
11,786 | $3.08 | 1,028,169 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A 2033-02-01 |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
640,000 | $0 | 1,679,959 (Direct) |
View |
| 2022-12-30 Option Award |
2023-02-03 5:01 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
4 | $0.867 | 1,679,959 (Direct) |
View |
| 2022-06-29 Option Award |
2022-11-01 11:07 am |
N/A 2032-06-29 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2022-09-10 Option Award |
2022-09-13 4:30 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
80,000 | $0 | 1,039,955 (Direct) |
View |
| 2021-12-31 Option Award |
2022-02-02 6:01 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
1,470 | $13 | 1,401,002 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 6:01 pm |
N/A 2032-01-31 |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
500,000 | $0 | 1,401,002 (Direct) |
View |
Ownership |
2021-05-06 9:25 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott See Remarks |
0 | $0 | 1,596,050 (Direct) |
View |
| 2020-12-11 Option Award(A) |
2021-01-26 7:02 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-12-11 Option Award |
2021-01-11 4:45 pm |
N/A 2030-12-11 |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
16,500 | $0 | 16,500 (Direct) |
View |
Ownership |
2020-10-01 6:38 pm |
N/A N/A |
ESSA Pharma Inc. | EPIX | Requadt Scott Director |
0 | $0 | 92,500 (Direct) |
View |